CVS beats on earnings, remains mum on 2025 revenue guidance
CVS (CVS) reported fourth quarter and full-year 2024 earnings Wednesday, beating Wall Street's expectations and sending its stock up 15% for the day. Full-year revenue came in at $372.8 billion, while ...
CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...
CVS Health price target raised to $70 from $66 at Deutsche Bank
Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...